Literature DB >> 12536237

Interferon-gamma secretion and perforin expression are impaired in CD8+ T lymphocytes from patients with undifferentiated carcinoma of nasopharyngeal type.

Stefania Zanussi1, Emanuela Vaccher, Cristina Caffau, Chiara Pratesi, Cinzia Crepaldi, Maria Teresa Bortolin, Rosamaria Tedeschi, Doriano Politi, Luigi Barzan, Umberto Tirelli, Paolo De Paoli.   

Abstract

An efficent antitumor and antiviral cellular immune response requires optimal interferon-gamma (IFN-gamma) secretion and perforin expression in CD8(+) T cells. The aim of this study was to define whether CD4(+) and CD8(+) T cells from patients with undifferentiated carcinoma of nasopharyngeal type (UCNT), a tumor regularly associated with the Epstein-Barr virus (EBV), have abnormal phenotype profiles, cytokine production, perforin and CD3-zeta expressions. Our data showed that CD4 and CD8 subset distribution was not grossly altered in the peripheral blood of UCNT patients, while tumor biopsies contained an increased proportion of CD8(+) T cells. The analysis of the CD4(+) subset showed a defect in interleukin-2 (IL-2) production and a moderate increase of IL-10 production, a situation consistent with a Th1/Th2 imbalance. We have also demonstrated that CD8(+) lymphocytes from UCNT patients had a marked impairment of IFN-gamma secretion and perforin expression. This impairment was not related to the presence of detectable EBV DNA in the plasma. In UCNT patients, the blockade of the perforin pathway and of IFN-gamma production may constitute important mechanisms for immune escape by the tumor and for impaired control of EBV replication.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12536237     DOI: 10.1007/s00262-002-0333-z

Source DB:  PubMed          Journal:  Cancer Immunol Immunother        ISSN: 0340-7004            Impact factor:   6.968


  12 in total

1.  Autograft HIV-DNA load predicts HIV-1 peripheral reservoir after stem cell transplantation for AIDS-related lymphoma patients.

Authors:  Stefania Zanussi; Maria Teresa Bortolin; Chiara Pratesi; Rosamaria Tedeschi; Giancarlo Basaglia; Luciano Abbruzzese; Mario Mazzucato; Michele Spina; Emanuela Vaccher; Umberto Tirelli; Maurizio Rupolo; Mariagrazia Michieli; Michele Di Mascio; Paolo De Paoli
Journal:  AIDS Res Hum Retroviruses       Date:  2015-01       Impact factor: 2.205

2.  Gamma interferon blocks gammaherpesvirus reactivation from latency.

Authors:  Ashley L Steed; Erik S Barton; Scott A Tibbetts; Daniel L Popkin; Mary L Lutzke; Rosemary Rochford; Herbert W Virgin
Journal:  J Virol       Date:  2006-01       Impact factor: 5.103

3.  Serum antibody response to lytic and latent Epstein-Barr virus antigens in undifferentiated nasopharyngeal carcinoma patients from an area of nonendemicity.

Authors:  Rosamaria Tedeschi; Elisa Pin; Debora Martorelli; Ettore Bidoli; Alessia Marus; Chiara Pratesi; Maria Teresa Bortolin; Stefania Zanussi; Emanuela Vaccher; Riccardo Dolcetti; Paolo De Paoli
Journal:  Clin Vaccine Immunol       Date:  2007-02-28

4.  Increase in tumour-infiltrating lymphocytes with regulatory T cell immunophenotypes and reduced zeta-chain expression in nasopharyngeal carcinoma patients.

Authors:  W K Yip; M A Abdullah; S M Yusoff; H F Seow
Journal:  Clin Exp Immunol       Date:  2009-03       Impact factor: 4.330

5.  IL-6/NOS2 inflammatory signals regulate MMP-9 and MMP-2 activity and disease outcome in nasopharyngeal carcinoma patients.

Authors:  Ahmed-Amine Zergoun; Abderezak Zebboudj; Sarah Leila Sellam; Nora Kariche; Djamel Djennaoui; Samir Ouraghi; Esma Kerboua; Zine-Charaf Amir-Tidadini; Dalia Chilla; Fatima Asselah; Chafia Touil-Boukoffa; Taha Merghoub; Mehdi Bourouba
Journal:  Tumour Biol       Date:  2015-10-09

6.  Association between the expression of IL-10 and T cell activation proteins loss in early breast cancer patients.

Authors:  Leticia Llanes-Fernández; Maria del Carmen Arango-Prado; Juan Manuel Alcocer-González; Marta Elena Guerra-Yi; Sonia Franco-Odio; Rolando Camacho-Rodríguez; Vicente Madrid-Marina; Reyes Tamez-Guerra; Cristina Rodríguez-Padilla
Journal:  J Cancer Res Clin Oncol       Date:  2008-07-24       Impact factor: 4.553

7.  Exosomes released by EBV-infected nasopharyngeal carcinoma cells convey the viral latent membrane protein 1 and the immunomodulatory protein galectin 9.

Authors:  Cécile Keryer-Bibens; Catherine Pioche-Durieu; Cécile Villemant; Sylvie Souquère; Nozomu Nishi; Mitsuomi Hirashima; Jaap Middeldorp; Pierre Busson
Journal:  BMC Cancer       Date:  2006-12-08       Impact factor: 4.430

8.  High serum levels of soluble CD40-L in patients with undifferentiated nasopharyngeal carcinoma: pathogenic and clinical relevance.

Authors:  Laura Caggiari; Massimo Guidoboni; Emanuela Vaccher; Luigi Barzan; Giovanni Franchin; Annunziata Gloghini; Debora Martorelli; Paola Zancai; Maria Teresa Bortolin; Mario Mazzucato; Diego Serraino; Antonino Carbone; Paolo De Paoli; Riccardo Dolcetti
Journal:  Infect Agent Cancer       Date:  2007-03-01       Impact factor: 2.965

9.  Revisiting immunosurveillance and immunostimulation: Implications for cancer immunotherapy.

Authors:  Christine V Ichim
Journal:  J Transl Med       Date:  2005-02-08       Impact factor: 5.531

10.  Expression of indoleamine 2,3-dioxygenase in nasopharyngeal carcinoma impairs the cytolytic function of peripheral blood lymphocytes.

Authors:  Peng Liu; Bai-Lu Xie; Shao-Hui Cai; Yun-Wen He; Ge Zhang; Yan-Mei Yi; Jun Du
Journal:  BMC Cancer       Date:  2009-11-30       Impact factor: 4.430

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.